The Connecticut Hospice Inc. recently expanded its disease-specific program for dementia patients, dubbed Magnolia Care. The program, which launched three years ago, offers specialized services for patients with dementia-related conditions nearing the end of life. Patients with dementia-related conditions often face more complicated end-of-life trajectories that require caregivers to have a deeper well of supportive […]
Alzheimer’s Association
Data are reshaping the health care space, and hospice is no exception. Data has played a large role in the ability to gauge the impact of end-of life care. Hospice providers have needed a window into access and utilization, as well as how lawmakers are shaping policies around health care. This article is the second […]
Prevalent care models for neurological illnesses could be improved by more extensive integration of palliative care, recent research has found. A team of international researchers reviewed prior studies of care models for treating Parkinson’s disease, multiple sclerosis, dementia and other neurological diseases. They found that the development of an evidence-based framework for early and ongoing […]
A growing number of patients with various dementia-related conditions will need end-of-life care in coming years. Hospices preparing for rising demand are facing compliance challenges, as these patients often require longer hospice stays. Patients with Alzheimer’s and other neurological degenerative disorders have health trajectories that are difficult to project, especially as they approach the end […]
Rippl, a new company offering mental health care to seniors, began operations today following a $32 million seed funding round. Rippl’s services focus on seniors suffering from dementia and other neurocognitive conditions. ARCH Venture Partners and General Catalyst led the investment round with participation from GV, F-Prime Capital, and Mass General Brigham Ventures. The company […]
Terminally ill patients suffering from dementia are more likely to receive life-sustaining treatments when children versus spouses were involved as decision-makers, according to recent research. The difference in end-of-life treatment choices suggests that more work needs to be done to ensure that surrogate decision makers and care teams are aware of patient preferences as early […]